NanJing Pharmaceutical Co Ltd
SSE:600713
NanJing Pharmaceutical Co Ltd
Current Portion of Long-Term Debt
NanJing Pharmaceutical Co Ltd
Current Portion of Long-Term Debt Peer Comparison
Competitive Current Portion of Long-Term Debt Analysis
Latest Figures & CAGR of Competitors
Company | Current Portion of Long-Term Debt | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
NanJing Pharmaceutical Co Ltd
SSE:600713
|
Current Portion of Long-Term Debt
¥2.3B
|
CAGR 3-Years
300%
|
CAGR 5-Years
277%
|
CAGR 10-Years
28%
|
|
Sinopharm Group Co Ltd
HKEX:1099
|
Current Portion of Long-Term Debt
¥76.3B
|
CAGR 3-Years
11%
|
CAGR 5-Years
9%
|
CAGR 10-Years
14%
|
|
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
|
Current Portion of Long-Term Debt
¥3B
|
CAGR 3-Years
-31%
|
CAGR 5-Years
30%
|
CAGR 10-Years
56%
|
|
Jointown Pharmaceutical Group Co Ltd
SSE:600998
|
Current Portion of Long-Term Debt
¥2.1B
|
CAGR 3-Years
7%
|
CAGR 5-Years
192%
|
CAGR 10-Years
10%
|
|
C
|
China National Medicines Corp Ltd
SSE:600511
|
Current Portion of Long-Term Debt
¥74.1m
|
CAGR 3-Years
-2%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
Huadong Medicine Co Ltd
SZSE:000963
|
Current Portion of Long-Term Debt
¥162.9m
|
CAGR 3-Years
47%
|
CAGR 5-Years
16%
|
CAGR 10-Years
N/A
|
See Also
What is NanJing Pharmaceutical Co Ltd's Current Portion of Long-Term Debt?
Current Portion of Long-Term Debt
2.3B
CNY
Based on the financial report for Mar 31, 2024, NanJing Pharmaceutical Co Ltd's Current Portion of Long-Term Debt amounts to 2.3B CNY.
What is NanJing Pharmaceutical Co Ltd's Current Portion of Long-Term Debt growth rate?
Current Portion of Long-Term Debt CAGR 10Y
28%
Over the last year, the Current Portion of Long-Term Debt growth was 65%. The average annual Current Portion of Long-Term Debt growth rates for NanJing Pharmaceutical Co Ltd have been 300% over the past three years , 277% over the past five years , and 28% over the past ten years .